An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer

被引:19
|
作者
Zhao, Nan [1 ]
Yang, Ruijie [1 ]
Wang, Junjie [1 ]
Zhang, Xile [1 ]
Li, Jinna [1 ]
机构
[1] Peking Univ, Hosp 3, Dept Radiat Oncol, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
MODULATED RADIATION-THERAPY; ARC THERAPY; HELICAL TOMOTHERAPY; PLAN QUALITY; IMRT; VMAT; RADIOTHERAPY; OPTIMIZATION; VOLUME; EFFICIENCY;
D O I
10.1155/2015/613060
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The study is to investigate a Hybrid IMRT/VMAT technique which combines intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) for the treatment of nonsmall cell lung cancer (NSCLC). Two partial arcs VMAT, 5-field IMRT, and hybrid plans were created for 15 patients with NSCLC. The hybrid plans were combination of 2 partial arcs VMAT and 5-field IMRT. The dose distribution of planning target volume (PTV) and organs at risk (OARs) for hybrid technique was compared with IMRT and VMAT. The monitor units (MUs) and treatment delivery time were also evaluated. Hybrid technique significantly improved the target conformity and homogeneity compared with IMRT and VMAT. The mean delivery time of IMRT, VMAT, and hybrid plans was 280 s, 114 s, and 327 s, respectively. The mean MUs needed for IMRT, VMAT, and hybrid plans were 933, 512, and 737, respectively. Hybrid technique reduced V-5, V-10, V-30, and MLD of normal lung compared with VMAT and spared the OARs better with fewer MUs with the cost of a little higher V-5, V-10, and mean lung dose (MLD) of normal lung compared with IMRT. Hybrid IMRT/VMAT can be a viable radiotherapy technique with better plan quality.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Surgical Treatment of Metachronous Nonsmall Cell Lung Cancer
    Haraguchi, Shuji
    Koizumi, Kiyoshi
    Hirata, Tomomi
    Hirai, Kyoji
    Mikami, Iwao
    Kubokura, Hirotoshi
    Nakajima, Yuki
    Shimizu, Kazuo
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 16 (05) : 319 - 325
  • [42] The Role of Proteasome Inhibition in Nonsmall Cell Lung Cancer
    Escobar, Mauricio
    Velez, Michel
    Belalcazar, Astrid
    Santos, Edgardo S.
    Raez, Luis E.
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [43] Controversies in Mediastinal Staging for Nonsmall Cell Lung Cancer
    Ashok, Apurva
    Jiwnani, Sabita S.
    Karimundackal, George
    Bhaskar, Maheema
    Shetty, Nitin S.
    Tiwari, Virendra Kumar
    Niyogi, Devayani M.
    Pramesh, C. S.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (05) : 406 - 414
  • [44] PALLIATIVE CHEMOTHERAPY FOR NONSMALL CELL LUNG-CANCER
    ADELSTEIN, DJ
    SEMINARS IN ONCOLOGY, 1995, 22 (02) : 35 - 39
  • [45] Chemotherapy in elderly patients with nonsmall cell lung cancer
    Veluswamy, Rajwanth R.
    Levy, Benjamin
    Wisnivesky, Juan P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2016, 22 (04) : 336 - 343
  • [46] Treatment of non-small cell lung cancer: advances following the introduction of PET-CT and IMRT/VMAT
    Muster, Julian
    Alt, Niklas Josua
    Edelmann, Marcus
    Anczykowski, Mahalia Zoe
    Zwerenz, Carla Marie
    Schirmer, Markus Anton
    Overbeck, Tobias Raphael
    Braulke, Friederike
    Guhlich, Manuel
    Shafie, Rami El
    Rieken, Stefan
    Leu, Martin
    Droege, Leif Hendrik
    STRAHLENTHERAPIE UND ONKOLOGIE, 2025,
  • [47] Update in PET imaging of nonsmall cell lung cancer
    Rohren, EM
    Lowe, VJ
    SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (02) : 134 - 153
  • [48] SHOULD NONSMALL CELL-CARCINOMA OF THE LUNG BE TREATED WITH CHEMOTHERAPY - PRO - CHEMOTHERAPY IS FOR NONSMALL CELL LUNG-CANCER
    MASTERS, GA
    VOKES, EE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (05) : 1285 - 1287
  • [49] Preoperative staging for advanced nonsmall cell lung cancer
    Fukuse, T
    Wada, H
    Tanaka, F
    Yanagihara, H
    Hirata, T
    Hitomi, S
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 957 - 960
  • [50] INTRAOPERATIVE BRACHYTHERAPY IN NONSMALL CELL LUNG-CANCER
    NORI, D
    SEMINARS IN SURGICAL ONCOLOGY, 1993, 9 (02): : 99 - 107